LGVN
USDLongeveron Inc. Class A Common Stock
$0.800-0.020 (-2.439%)
即時價格
Healthcare
生物科技
美國
價格圖表
Loading Chart...
關鍵指標
市場指標
開盤
$0.820
最高
$0.820
最低
$0.800
交易量
0.38M
公司基本面
市值
16.8M
行業
生物科技
國家
United States
交易統計
平均交易量
0.95M
交易所
NCM
貨幣
USD
52週範圍
最低 $0.633當前 $0.800最高 $2.31
相關新聞
GlobeNewswire
Longeveron® to Report Third Quarter 2025 Financial Results and Host Conference Call on November 4, 2025
MIAMI, Oct. 28, 2025 (GLOBE NEWSWIRE) -- Longeveron Inc. (NASDAQ:LGVN), a clinical stage biotechnology company developing cellular therapies for life-threatening, rare pediatric and chronic aging-related conditions,
查看更多
GlobeNewswire
Longeveron® Co-Founder and Chief Science Officer Dr. Joshua Hare Interviewed on NPR's BioTech Nation Discussing Potential Breakthrough Stem Cell Therapy for Hypoplastic Left Heart Syndrome (HLHS), a Rare Pediatric Congenital Heart Defect
Laromestrocel is a proprietary, scalable, allogeneic cellular therapy being evaluated to improve the clinical outcomes of children with HLHSFull enrollment achieved for pivotal Phase 2b clinical trial (ELPIS II)
查看更多
